Rachel Gragg

Rachel Gragg is a highly accomplished professional with extensive experience in pharmaceutical sales, specializing in neurology and cardiovascular markets. Currently serving as a Territory Business Manager at Merz Therapeutics since December 2021, Rachel has successfully developed key accounts, improved clinical support for XEOMIN, and achieved significant territory growth. Prior to this role, Rachel excelled at Teva Pharmaceuticals as an Executive Neurology Sales Specialist, receiving multiple awards and accolades for performance and leadership from 2015 to 2021. Rachel's impressive track record includes recognition at Bayer and Quintiles Johnson & Johnson, where Rachel consistently ranked in the top percentages of sales performance. With a Bachelor of Science degree in Biology from Oklahoma State University, Rachel combines a strong educational background with a proven ability to drive results across diverse healthcare sectors.